Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

9.43
Delayed Data
As of Aug 31
 +0.69 / +7.89%
Today’s Change
6.01
Today|||52-Week Range
12.77
-2.38%
Year-to-Date
No recent news for Veracyte Inc.

Today’s Trading

Previous close8.74
Today’s open8.72
Day’s range8.72 - 9.69
Volume78,977
Average volume (3 months)93,111
Market cap$241.8M
Dividend yield--
Data as of 08/31/2015

Growth & Valuation

Earnings growth (last year)+77.89%
Earnings growth (this year)+3.58%
Earnings growth (next 5 years)--
Revenue growth (last year)+74.51%
P/E ratioNM
Price/Sales5.47
Price/Book4.76

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...-0.54-8.00%
QTNTQuotient Ltd-0.10-0.61%
TROVTrovagene Inc-0.38-6.00%
OXFDOxford Immunotec Glo...+0.26+1.84%
Data as of 08/31/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$38.2M
Annual profit (last year)-$29.4M
Net profit margin-76.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bonnie H. Anderson
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers